Filing Details

Accession Number:
0001209191-14-030411
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-01 20:02:47
Reporting Period:
2014-04-29
Filing Date:
2014-05-01
Accepted Time:
2014-05-01 20:02:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596946 Quotient Ltd QTNTU In Vitro & In Vivo Diagnostic Substances (2835) 264719797
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1604877 Frederick Hallsworth Elizabeth House, 9 Castle Street
St Helier Y9 JE2 3RT
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2014-04-30 6,250 $0.00 31,504 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Employee Stock Option (right to buy) Acquisiton 2014-04-29 5,000 $0.00 5,000 $8.00
Ordinary Shares Ordinary Share Warrants Acquisiton 2014-04-30 6,250 $8.00 5,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 2024-04-29 No 4 A Direct
6,250 2014-07-24 2015-10-25 No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Ordinary Shares Option to Purchase Ordinary Shares $0.00 2014-02-13 2022-08-30 20,014 20,014 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2022-08-30 20,014 20,014 Direct
Footnotes
  1. In connection with Quotient Limited's initial public offering, 6,250 units were purchased on 4/30/2014 at a price of $8.00 per unit. Each unit consists of one Ordinary Share and one warrant to purchase 0.8 of one Ordinary Share. The units currently trade on NASDAQ. The Ordinary Shares and warrants comprising the units will begin trading separately on May 24, 2014, at which time trading of the units will be suspended and the units will be de-listed. Each warrant will be exercisable during the period commencing on July 24, 2014 and ending at 5:30 p.m. on October 25, 2015 at an exercise price of $8.80 per Ordinary Share.
  2. The option becomes exercisable in three equal annual installments beginning April 29, 2015.
  3. The exercise price will be paid in pounds sterling, at GBP0.91 per share.